Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-20 Purchase |
2023-04-24 10:28 am |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
299,402 | $0.71 | $212,575 | 743,804 (Direct) |
View |
| 2022-02-07 Purchase |
2022-02-07 3:50 pm |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
10,334 | $3.58 | $36,996 | 145,000 (Direct) |
View |
| 2022-01-19 Purchase |
2022-01-19 2:59 pm |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
5,000 | $3.89 | $19,450 | 134,666 (Direct) |
View |
| 2021-12-15 Purchase |
2021-12-15 11:19 am |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
5,000 | $3.89 | $19,450 | 129,666 (Direct) |
View |
| 2021-12-02 Purchase |
2021-12-02 4:34 pm |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
5,000 | $4.93 | $24,650 | 124,666 (Direct) |
View |
| 2021-11-19 Purchase |
2021-11-19 1:05 pm |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
5,000 | $5.25 | $26,250 | 119,666 (Direct) |
View |
| 2021-09-15 Purchase |
2021-09-15 3:39 pm |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
5,000 | $6.35 | $31,750 | 114,666 (Direct) |
View |
| 2020-12-11 Purchase |
2020-12-14 4:02 pm |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
20,000 | $0 | $0 | 119,666 (Direct) |
View |
| 2020-08-27 Purchase |
2020-08-28 4:06 pm |
Cyclo Therapeutics Inc. | CTDH | FINE N SCOTT Chief Executive Officer |
500,000 | $0 | $0 | 8,466,513 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-03 Option Award |
2024-06-05 5:08 pm |
N/A 2034-06-03 |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
266,354 | $0 | 266,354 (Direct) |
View |
| 2023-10-20 Exercise |
2023-10-23 06:05 am |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
299,402 | $0.71 | 1,073,146 (Direct) |
View |
| 2023-10-20 Exercise |
2023-10-23 06:05 am |
2023-04-20 2030-04-20 |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
299,402 | $0.125 | 1,073,146 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-09 5:11 pm |
N/A 2033-03-07 |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
98,706 | $0 | 98,706 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 4:32 pm |
N/A 2032-02-28 |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
74,907 | $0 | 74,907 (Direct) |
View |
| 2021-08-27 Option Award |
2021-08-30 7:02 pm |
N/A 2031-08-27 |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
57,300 | $0 | 57,300 (Direct) |
View |
| 2021-01-13 Option Award |
2021-01-25 8:01 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
10,000 | $0 | 109,666 (Direct) |
View |